Life Technologies Denies Allegations Made by Former Visigen CEO
January 20, 2010
Life Technologies Denies Allegations Made by Former Visigen CEO
The former CEO of Visigen, which was acquired in 2008 by Invitrogen, has alleged breach of contract, fraud, and negligent representation, all of which have been denied by Life Technologies.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Life Tech Defeats VisiGen Stakeholders in Arbitration of Breach-of-Contract, Fraud Suit
November 15, 2011 / In Sequence - Arbritration Panel Awards Former Executives of Applied Biosystems $17.4 Million for Lost Benefits
December 7, 2012 / GenomeWeb Daily News - Life Tech Found Guilty of IP Infringement as LabCorp Subsidiary Hits Firm with Separate Suit
November 2, 2012 / GenomeWeb Daily News - Pacific Biosciences Settles IP Litigation with Life Technologies, Helicos
May 2, 2012 / GenomeWeb Daily News - LabCorp's Esoterix Files Patent Infringement Suit Against Life Technologies
May 1, 2012 / GenomeWeb Daily News